SAILIFE — SAI Life Sciences Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapHigh Flyer

Annual income statement for SAI Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	PRESS
Standards:	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final
Revenue
Total Revenue	8,696	12,171	14,652	16,946
Cost of Revenue
Gross Profit	5,445	7,119	9,259	12,288
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	8,385	11,511	12,991	14,275
Operating Profit	311	661	1,661	2,671
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	97	164	1,092	2,277
Provision for Income Taxes
Net Income After Taxes	62.3	99.9	828	1,701
Net Income Before Extraordinary Items
Net Income	62.3	99.9	828	1,701
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	62.3	99.9	828	1,701
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.054	0.497	3.98	8.61